UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -33.3% | 58 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -66.7% | 58 | -51.3% | 0.00% | – |
| Q4 2019 | $9,000 | -100.0% | 119 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $23,146,000 | -7.5% | 296,169 | -29.4% | 0.04% | -10.3% |
| Q1 2019 | $25,017,000 | +155.2% | 419,392 | +23.3% | 0.04% | +129.4% |
| Q4 2018 | $9,804,000 | -67.6% | 340,183 | -59.1% | 0.02% | -62.2% |
| Q3 2018 | $30,277,000 | -11.5% | 832,012 | -8.1% | 0.04% | -13.5% |
| Q2 2018 | $34,210,000 | – | 905,023 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |